Background: Randomized clinical trials showed that laparoscopic colectomy (LC) is superior to open colectomy (OC) in short-term surgical outcomes; however, the generalizability among real-world patients is not clear.
article to questioning the external validity of the findings. Moreover, there is limited data on the comparative effectiveness of LC vs open colectomy (OC) in routine clinical practice where surgeon skills, treatment facility characteristics, and patient characteristics may be very different than existed during the randomized trials. Therefore, the generalizability of the benefits of LC demonstrated by the randomized clinical trials is subject to further examination of evidence from real-world colon cancer patients.
High hospital volume has been associated with increased likelihood of performing LC and favorable short-term outcomes for both OC and LC (16) (17) (18) . However, whether LC is safe in a diverse population across various sources of payers, providers, and types of facilities is still not clear. More importantly, to the best of our knowledge, surgeon volume has not been discussed extensively and the relationship between hospital volume and surgeon volume in achieving the incremental benefits of LC vs OC is less clear to patients, providers, and policy makers.
Therefore, the purpose of this study is to investigate the short-term comparative effectiveness of LC vs OC and the impact of hospital/surgeon volume on surgical outcomes using a contemporary cohort of stage I-III colon cancer patients who underwent curative surgical resection identified from the National Cancer Data Base (NCDB).
Methods

Study Population
The NCDB, jointly sponsored by the Commission on Cancer (CoC) of the American College of Surgeons and the American Cancer Society, is a nationwide oncology outcomes database based on more than 1400 Commission-accredited cancer programs, covering approximately 70% of new cancer cases in the United States (19) . Our cohort consisted of patients diagnosed with stage I-III colon cancer in 2010 and 2011, using the International Classification of Diseases for Oncology, 3rd Edition for sites (C18.0, C18.2-7) and histology codes (8140,8141-45, 8147, 8210, 8211, 8220, 8221, 8260-63, 8470, 8480, 8481, 8490). Patients were limited to those who had adenocarcinoma and underwent either curative LC or OC as their first course of treatment within 90 days after diagnoses. Patients were excluded if the primary site was appendix or missing, the primary surgery was for local tumor excision (eg, polypectomy), or contiguous organ resection was involved during colectomy (eg, small bowel, bladder, etc.) We also excluded patients who were either younger than age 18 years or older than 84 years at the time of diagnoses ( 
Statistical Methods
Descriptive statistics were used to compare the distributions of patient-, surgeon-, and hospital-level characteristics between LC and OC groups using the whole sample. Multilevel regressions with clustering at the hospital-level were performed to investigate the short-term benefits associated with LC (ie, 30-day mortality, 30-day unplanned readmission, and length of stay [LOS] ). In order to reduce the potential selection bias, a propensity score (PS) with 1:1 matching method was used to balance patient-level characteristics to create comparable LC and OC groups (20, 21) . The PS matching included all the variables of interest: colon cancer site, adequacy of nodal retrieval, tumor grade, margin status, lymphovascular invasion, extent of resection, tumor size, stage IIc T4 status, stage at diagnosis, CCI, year of colectomy, age, race/ethnicity, sex, urban living status, insurance type, facility type, high surgeon/hospital volume status, proxies for household income level, and region. The matched sample was generated using a matching algorithm with a caliper of 0.0001. Because multilevel analysis requires at least two observations per hospital, we excluded hospitals that performed only one colectomy during a particular year from our analysis.
Multilevel logistic regression was conducted for 30-day mortality and 30-day unplanned readmission, and multilevel Poisson regression was conducted for LOS. Both matched and unmatched analyses were multivariablely adjusted. Add itional analyses were conducted by stratifying the sample into four subsamples according to the volume measurement: low-volume surgeon low-volume hospital, high-volume surgeon low-volume hospital, low-volume surgeon high-volume hospital, and highvolume surgeon high-volume hospital. The rates of adjuvant chemotherapy initiation for stage III colon cancer patients within eight weeks after colectomy were compared between LC and OC groups. Sensitivity analyses were conducted to examine the robustness of our findings by excluding converted colectomies (LC completed only vs OC) and including the oldest age group (85 to 99 years). All analyses were intent-to-treat, ie, converted cases were included in the LC group for the primary analysis.
All multilevel regression analyses were performed using SAS version 9.3 (SAS Institute Inc, Cary, NC) Proc Glimmix, and propensity scores were constructed using STATA 13.1 (StataCorp LP, College Station, Texas) Command Teffects. Statistical comparisons were two-sided, and significance was defined as a P value of less than .05. 
Results
Study Population
Propensity Score Analysis
We anticipated that comparison of the two treatment groups would demonstrate statistical differences by factors (eg, age, comorbidity status, and payer type) that were likely to be associated with both the treatment assignment and our outcomes of interest. We therefore performed a PS analysis based on all potential predictor variables for LC vs OC and identified two PS matched (1:1) cohorts for the primary comparisons. Following PS matching, the distribution of the covariables was fully balanced with 18 230 patients in each group, LC and OC ( Figure 2 and Table 1 ).
Clinical Outcomes Before and After Propensity Score Matching
In the unmatched analyses, multilevel logistic regression results demonstrated that when compared with OC, LC was associated with statistically significant reduction in 30-day mortality (1.3% vs 2.8%, odds ratio [OR] = 0.54, 95% confidence interval [CI] = 0.47 to 0.63, P < .001), rate of 30-day unplanned readmission (4.8% vs 5.5%, OR = 0.87, 95% CI = 0.79 to 0.96, P = .003), and LOS (median 5 vs 6 days, incident rate ratio [IRR] = 0.82, 95% CI = 0.8 to 0.83, P < .001) ( Table 2) . Following PS matching, LC remained associated with a lower rate of 30-day mortality (1.3% vs 2.3%, OR = 0.59, 95% CI = 0.49 to 0.69, P < .001) and shorter LOS (median 5 vs 6 days, IRR = 0.83, 95% CI = 0.8 to 0.84, P < .001), but had only a modest association with rate of 30-day unplanned readmission (4.8% vs 5.1%, OR = 0.90, 95% CI = 0.81 to 1.0, P = .052) ( Table 2 ). Not surprisingly, factors independently associated with increased 30-day mortality also included older age, greater comorbidity, lower socioeconomic status, larger and more advanced tumors, and positive surgical margin (Tables 3 and 4) .
Impact of Facility and Surgeon Volume
Because of the learning curve associated with LC and as prior randomized trials have included experienced surgical investigators and major academic/research centers, we sought to further evaluate the impact of facility type, annual hospital * All statistical tests were two-sided. LC = laparoscopic colectomy; NCI = National Cancer Institute; OC = open colectomy; PI = Pacific Islander; PS = propensity score. † P value calculated using Pearson's chi-squared test. ‡ Right colon includes cecum, ascending colon, and hepatic flexure of colon, transverse colon includes transverse colon and splenic flexure of colon, and left colon includes descending colon and sigmoid colon. § High-volume surgeon is defined as more than six colectomies within a particular year; high-volume hospital is defined as more than 36 colectomies within a particular year, both of which are the top 10 th percentiles. Table 1 . Continued volume, and annual surgeon volume on the short-term benefits associated with LC. In our sample, the 90 th percentile cutoff points were 6 colectomies for high surgeon volume and 36 colectomies for high hospital volume annually. Among 8414 individual surgeons that were identified in our sample, 44.4% performed OC only. Moreover, among 954 high-volume surgeons, 51.5% performed OC more frequently than LC. Prior to PS matching, LC was more likely to be performed by highvolume surgeons in high-volume hospitals, and high surgeon volume was associated with lower rate of 30-day mortality and shorter LOS (Tables 3 and 4; Supplementary Table 1, available  online) .
Despite the hospital and surgeon volume effects on the likelihood of performing LC vs OC, the benefits of LC in terms of 30-day mortality and LOS were observed across all hospital and surgeon volume strata before and after PS matching (Table 5 ). There was no statistically significant effect of the type of reporting facility on 30-day mortality, 30-day unplanned readmission, or LOS.
Time to Initiation of Adjuvant Chemotherapy
We further evaluated the impact of surgical approach on the ability to initiate adjuvant chemotherapy within the recommended eight-week window among patients with stage III colon cancer. After PS matching, the overall rate of adjuvant chemotherapy was higher among patients undergoing LC than OC (72.3% vs 67.0%, P < .001). Moreover, among patients who did receive adjuvant chemotherapy, LC patients were more likely to receive chemotherapy within eight weeks than OC patients (56.56% vs 49.57%, P < .001) (Figure 3 ).
Discussion
In this study, we investigated the short-term comparative effectiveness of LC vs OC among stage I-III colon cancer patients in 2010 and 2011 using propensity score matching. Our results showed that in routine clinical practice LC is associated with a lower 30-day mortality rate, a shorter LOS, and a modest reduction in the rate of unplanned readmissions. Importantly, among patients with stage III colon cancer, those who underwent LC were associated with a higher likelihood of receiving adjuvant chemotherapy and receiving it without delay than those who underwent OC.
The short-term benefits and the oncologic efficacy of LC for cancer have been described in previous studies. However, these data have primarily come from high-volume institutions and from clinical trials where the participating surgeons have demonstrated expertise in LC for cancer (4) (5) (6) (7) . Therefore, the generalizability of the conclusions from randomized clinical trials to routine clinical practice in a diverse patient population with various types of payers and providers has not been established. We analyzed data from the NCDB, which is a hospital-based cancer registry data (22) . Our study included more than 8400 surgeons and 1300 hospitals, which is highly representative of colon cancer care in the United States. We noted that the short-term benefits associated with the receipt of LC could be achieved in both low-and high-volume hospitals and by low-and high-volume surgeons. By utilizing the method of PS matching to minimize the effect of treatment selection bias, we demonstrate the generalizability of our findings to the broad community of colon cancer patients and providers and also highlight a potential priority area for improving treatment outcomes and reducing variation. Prior evaluation of LC within the NCDB examined surgery performed prior to the publication of the US intergroup randomized trial (23) . As a result, the laparoscopic approach was utilized in less than 5% of the cohort, suggesting substantial susceptibility to the influence of institutional and surgeon experience. Moreover, the corresponding analysis could not account for treatment selection (23, 24) . Our analysis showed that the contemporary utilization of LC for cancer was over 41% in 2010 and 2011, which is the highest US rate documented in the literature but still with room for improvement (23, 25, 26) . Currently, the laparoscopic approach is available to just under one in two eligible patients with nonmetastatic colon cancer.
The present study also shows that LC is performed at a wide variety of facility types and among both low-and high-volume hospitals and surgeons with more than 64% of LC cases performed in community hospitals and more than 70% performed by low-volume surgeons, demonstrating the widespread availability of the laparoscopic approach. Stratified and propensity score matched analysis demonstrated that the benefits of LC are realized across the diverse spectrum of cancer programs and surgeons. However, close to half of all surgeons still performed only OC, and more than half of high-volume surgeons performed OC more frequently than LC in their routine clinical practice. While clearly not all patients with colon cancer will be candidates for a laparoscopic approach, the use of LC vs OC represents considerable practice variation in the surgical treatment of colon cancer. Moreover, as utilization of hospital days is one of the key cost-drivers of a hospitalization episode, improving LC utilization has the potential to markedly reduce the overall costs of treating patients with colon cancer. Our results indicate that in order for more patients to realize benefits associated with LC at the national level, policies should create incentives within the healthcare system to expand of the capability to perform LC through education and training.
Our findings of shorter length of stay and reduced mortality are consistent with a recent study that examined the perioperative outcomes between LC and OC using the US National Inpatient Sample database (27) . However, by using the NCDB, we were additionally able to account for tumor characteristics and evaluate oncologic treatment outcomes. Although the duration of follow-up in this study was too short to address long-term effects on survival, it is highly notable that among stage III patients, LC was associated with improved odds of receiving adjuvant chemotherapy compared with OC. Moreover among stage III patients who did receive adjuvant chemotherapy, LC patients were more likely to initiate chemotherapy within eight weeks, an important quality-of-care endpoint as delays beyond this have been associated with decreased survival (28) . These findings were observed after balancing all covariates through PS matching.
Recent implementation of enhanced recovery-after-surgery (ERAS) pathways and modern approaches to perioperative management have been shown to have the potential to reduce LOS and perioperative complications following OC (29, 30) . The combination of LC and ERAS may have the potential to yield further benefits and is now the subject of ongoing randomized studies (31) (32) (33) .
Our study has a number of strengths. Conventional regression modeling for our primary comparison does not address threats to internal validity because of treatment selection bias when comparing LC to OC, and statistically significant differences exist between the groups among the covariables. PS matching methods are widely recognized to be an important strategy for reducing confounding because of selection bias by balancing on the background covariables (34, 35) . Second, we utilized multilevel regression analysis to reduce clustering effects at the hospital-level. Intrahospital variations exist when patients who received colectomies at one hospital on average have better or worse outcomes compared with those who received colectomies at another hospital (36, 37) . This could be because of differences in clinical pathways between hospitals.
Despite these strengths, there are also several limitations. At the time of the analysis, there was no information about the long-term oncologic outcomes. Moreover, we were unable to distinguish between emergent vs elective indications for colectomy, although our findings were robust across a variety of practice environments. In our analysis of surgeon and hospital article Table 4 . Multilevel regression results of associations between patient-, surgeon-, and hospital-level factors and short-term surgical outcomes of LC vs OC for stage I-III colon cancer patients using the PS matched sample* Select variables (n = 36 460) article volume, it should be acknowledged that even the "high" volume surgeons were only performing six or more colectomies each year; however, this suggests greater generalizability of our findings to the average surgeon's practice. While the propensity score matching is an important tool for accounting for selection bias as evidenced by the balanced covariables, the analysis may still be at risk for hidden biases. Some important risk factors that could adversely impact the likelihood of receiving LC, such as surgery's emergency status, existence of extensive adhesions/ contraindications to pneumoperitoneum, and anatomical selection of patients, were not available in the NCDB. Patients requiring urgent colectomy may require OC, which may enlarge the differences in short-term outcomes between LC and OC groups. Additional sensitivity analyses have been conducted to account for urgent cases by using the timing of colectomy from diagnosis as a proxy measurement, but the findings remained similar to our main analyses. Instrumental variable analysis could be another potential approach to address the selection bias; however, there are challenges to identifying a valid instrument that is itself not subject to limitations. The large number of colectomies included in the analysis and the robustness of our findings through alternative analyses provide important information to clinicians, policy makers, and the general public about the comparative effectiveness of LC vs OC in routine clinical practice. Compared with open colectomy, laparoscopic colectomy is associated with a lower 30-day mortality rate, shorter length of hospital stay, and moderate improvement in unplanned readmissions in routine clinical practice. Moreover, laparoscopic colectomy is associated with improved rates of adjuvant chemotherapy administration for patients with stage III colon cancer. We have demonstrated the generalizability of the benefits of laparoscopic colectomy found in randomized clinical trials among real-world patients where the majority of colectomies were performed in community cancer programs. However, more than half of patients still undergo open resection. Wider diffusion of laparoscopy at the population level with incentives to improve laparoscopic skills acquisition through training and monitoring of outcomes, particularly among current high volume surgeons who perform only open colectomy, may benefit patients and improve the efficiency of colon cancer care throughout the healthcare system.
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